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Abstract. We performed serological and pathological studies on 495 patients with Cha- 
gas’ disease from different areas of Bolivia. Eighty-nine Trypanosoma cruzi strains, isolated 
by xenodiagnosis, were characterized by 12 isoenzyme loci and were related to the presence 
of cardiac changes and enteric disease with megacolon. There was a high heterogeneity of 
human zymodemes, presenting evidence of 2 predominant zymodemes genetically dissim- 
ilar from each other and ubiquitous in Bolivia. The frequencies of these predominant 
zymodemes among strains from patients were compared to strains from triatomine bugs 
previously studied. We observed mixtures of different zymodemes within the same patient, 
a phenomenon seen previously in Bolivian patients. There was no apparent difference of 
pathogenicity between the 2 more frequent zymodemes isolated from humans. 
Trypanosoma cruzi, the agent of Chagas’ dis- 
ease, is associated with 2 main clinical forms, 
cardiac and intestinal. These clinical forms are 
not equally distributed within the geographical 
range of the disease, and it has been proposed 
that T. cruzi zymodeme distribution could ex- 
plain this fact.‘ We present here pathological, 
serological, and parasitological studies, involv- 
ing 495 patients from Bolivia, showing the di- 
versity of the clinical forms and the distributions 
of these clinical forms and T. cruzi zymodemes 
isolated from human. The relationships are pre- 
sented and discussed. 
MATERIALS AND METHODS 
Patients 
Two groups were examined at different times 
and under different conditions. Group I, con- 
sisting of 364 patients, was from the villages of 
Chiwisivi (Department La Paz) at 2,800 meters 
above sea level (mas), Salinas (Department San- 
ta-Cruz) at 800 mas, and Camiri (Department 
Santa-Cruz) at 800 mas (Table 1). After clinical 
examination, electrocardiography was per- 
formed. Serodiagnostic procedures included in- 
direct immunofluorescence IgG (IMF), and 
ELISA.* These patients were then classified as 
follows, according to the results of these tests: 
Positive serology and positive cardiopathy- 
IMF and ELISA tests positive, ECG with ab- 
normalities as in Groups II and III of the WHO 
clas~ification.~ 
Positive serology and negative cardiopathy- 
IMF and ELISA tests positive, normal ECG. 
Negative serology and positive cardiopathy- 
IMF and ELISA tests negative, ECG with ab- 
normalities as in Groups II and III of the WHO 
clas~ification.~ 
Negative serology and negative cardiopathy- 
IMF and ELISA tests negative, normal ECG. 
The second group was composed of 13 1 pa- 
tients, all exhibiting a positive serology (serodi- 
agnosis as noted above). They originated from 
different endemic regions of Bolivia, although 
108 had been living in La Paz (3,600 mas) for 
at least 5 years (average time spent in La Paz: 10 
years). The endemic areas where the patients had 
spent their childhoods or the first endemic area 
where they had spent > 1 year were considered 
the geographical origins of infection (Table 2). 
The following tests were conducted ECG, x-ray 
of the right anterior side of the esophagus, and 
x-ray of colon after barium washing (4 x-ray fìlms. 
Group II patients were then classified as follows: 
Asymptomatic-positive serology, normal 
ECG, normal esophagus and colon. 
Cardiopathy- positive serology, ECG with 
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TABLE 1 
Serology, cardiac pathology, and zymodemes of Group I patients by locality 
Positive serology Negative serology 
Localities Sex n c+t C-t  Cf C- Zvmodemesl 
Chiwisivi M 113 27 37 11 38 9 
Salinas M 24 7 16 O 1 
F 22 6 15 O 1 
Camiri M 88 13 63 O 12 2, 37, 38,39,42 
F 117 17 71 O 29 
- 
Total 364 272 (74.7%) 92 (25.3%) 
* AAer Tibayrenc and otherssJ2; zymodemes isolated from Triatoma infistans. 
t Ct = ECG presenting abnormalities Groups II and III of the WHO classification.' 
$ C- Normal ECG. 
abnormalities as in Group II and III of the WHO 
cla~sification,~ normal esophagus and colon. 
Megacolon-positive serology, colon with ab- 
normal length (DI, DII, or DIII, according to the 
degree of hypertrophy) and/or enlargement (MI, 
MII, or MIII, according to the degree of hyper- 
trophy), normal ECG, normal esophagus. The 
abnormal length of the colon (DI) observed in 
the patients having spent > 5  years in highland 
was considered insignificant because this is fre- 
quently seen in individuals living in highlands 
(La Paz, 3,800 mas; Cochabamba and Sucre, 
2,600 mas). 
Megaoesophagus-esophagus with abnormal 
di la ta t i~n,~ normal ECG and colon. 
Associated-positive serology, ECG with ab- 
normalities, and megaoesophagus and/or me- 
gacolon as mentioned above. 
Zymodeme sampling 
By drawn xenodiagnosis, 35 strains were iso- 
lated from patients of the Group II; 10 others 
were isolated from patients who had ECG exam 
only, and 44 others were isolated from patients 
who had not been examined otherwise. All pa- 
tients originated from various Bolivian endemic 
areas (Table 3) and all presented a positive se- 
rology. 
Zyinodeme identgcation 
T. cruzi strains were isolated by xenodiagnosis 
using a method previously des~ribed.~ The xe- 
nodiagnosis was performed with 30 laboratory- 
reared Triatoma infestans (third larval stage). 
Strains of T. cruzi from these patients were grown 
in LIT medium. Eleven enzyme systems corre- 
sponding to 12 genetic loci were assayed glucose- 
6-phosphate dehydrogenase (E.C. 1.1.1. 49,  
G6PD), glucose-6-phosphate isomerase 
(E.C.5.3.1.9., GPI), glutamate dehydrogenase 
NAD+ (E.C. 1 4.1.2., GDH-NAD-?), glutamate 
dehydrogenase NADP+ (E.C. 1.4.1.4., GDH- 
NADP+), isocitrate dehydrogenase 
(E.C. 1.1.1.42, IDH), malate dehydrogenase (E.C. 
TABLE 2 
Pathologies of 131 chronic Bolivian chagasic patients from various endemic areas 
Geographical 
origin of 
patients 
Camargo 
Camiri 
Cochabamba 
Potosi 
Santa-Cruz 
Sucre 
Tarija 
Tupiza 
Valle Grande 
Yungas 
Undetermined 
Total 
n - 
1 
4 
34 
5 
1 
38 
7 
9 
5 
7 
9 
131 
Clinical groups' 
A C MC MO AS 
1 O O O O 
3 O 1 O O 
3 1 1 O O 
2 3 5 O O 
2 O 4 O 1 
2 4 3 O O 
3 1 O 1 O 
4 O 3 O O 
4 2 2 O 1 
15 (44.1%) 7 (20.5%) 10 (29.4%) O (OYo) 2 (5.8%) 
20 (52.6Yo) 8 (21Yo) 6 (15.8%) O (0%) 6 (15.8%) 
59 (45%) 26 (19.8%) 35 (26.7%) 1 (0.07%) 10 (7.6%) 
~ 
All of these patients were examined in La Paz and presented a positive serology. 
* A  = asymptomatic, C = cardiopathy, MC = megacolon, MO = megaoesophagus, and AS = associated. 
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TABLE 3
Numbers ofpatìents infected by given zymodemes, or mixtures of zymodemes, with reference to their geographical 
origin 
Two zymodemes within 
the same patient 
Geographical Only one zymodeme ~ 
20+ 2 0 +  73. origin of 
patients n NPl 7 19 20 32 39 40 43 NP2 39 40 20 
Cochabamba 
Potosi 
santa-cruz 
Sucre 
Tarija 
Tupiza 
Valle Grande 
Yungas 
unknown 
Total 
33 O 1 2 6 0 2 2 0 0  O 1 1 0  
3 1 0 0 1 0 1 0 0  O 0 0 0  
10 O 0 2 0 0 6 1 0  O 1 0 0  
16 O 1 4 2 1 6 0 0  O 2 0 0  
1 0 0 0 1 0 0 0 0  O 0 0 0  
2 0 0 0 1 0 1 0 0  O 0 0 0  
1 0 0 0 1 0 0 0 0  O 0 0 0  
2 0 0 0 0 0 0 0 0  O 1 0 1  
21 O 0  3 6 0  5 0 2  1 4 0 0  
89 1 1  1 1 1 8  1 4 1  1 2  1 9 1 1  
NP = new profile. 
Zymodeme numbering is according to Tibayrenc and others? 
1.1.1.37, MDH), malate dehydrogenase (oxal- 
oacetate decarboxylating, NADP+), or malic en- 
zyme (E.C.l.l.l 40, ME), peptidase 1 (Ficin) 
(E.C.3.4.22.3., formerly E.C.3.4.4.12, PEP-1, 
substrate: Leucyl-leucyl-leucine), peptidase 2 
(Bromelain) (E.C.3.4.22.4., formerly 
E.C.3.4.4.24, PEP-2, . substrate: Leucyl-L-ala- 
nine), phosphoglucomutase (E.C.5.4.2.2., for- 
merly E.C.2.7. 5.1., PGM), and 6-phosphoglu- 
conate dehydrogenase (E.C. 1.1.1.44, 6PGD). 
Electrophoreses were performed on cellulose 
acetate plates using the method of Tibayrenc and 
others6 with slight modifications. Genetic inter- 
pretation of the zymograms and zymodeme 
numbering were performed as previously de- 
s ~ r i b e d . ~ , ~  
Statistical methods 
The chi-square h2) test or the modified xz test 
(small samples) were used for the different com- 
pansons. The phylogenetic relationships among 
the zymodemes evidenced have been evaluated 
by calculation of Nei’s standard genetic distanceg 
(measure of the number of codon differences per 
gene between 2 populations) and by the mini- 
mum-length Wagner network clustering meth- 
Od.8,10,11 
RESULTS 
Serological and electrographic study 
of Group I patients 
The study of 364 patients from 3 endemic areas 
revealed high rates of positive serology, ranging 
from 56.6% in Chiwisivi to 95.6% in Salinas. 
Women from Camiri presented a significantly 
higher number of positive serologies than men 
(x2 = 3.89, df = 1, P < 0.05); this result was not 
observed in Salinas. Men from Chiwisivi exhib- 
ited a significantly lower rate of positive serology 
than men from Camiri and Salinas (x2 = 20.66, 
P < lob3 and x2 = 13.12, P < df = 1, 
respectively). The difference observed between 
Camiri and Salinas was not statistically signifi- 
cant (0.85, P > 0.05). High rates of ECG ab- 
normalities in the whole populations were ob- 
served (Table 1): 14.6% in Camin, 28.2% in 
Salinas, and 33.6% in Chiwisivi. In Camiri and 
Salinas, ECG abnormalities were constantly as- 
sociated with positive serology. In contrast, in 
Chiwisivi, 11 patients with negative serology 
presented ECG abnormalities, although there was 
a significant association between positive serol- 
ogy and cardiopathy (x2 = 5.22, df = 1, P < 
0.05). Among the patients exhibiting a positive 
serology, the index of cardiopathy was higher in 
Chiwisivi than in Salinas, and higher in Salinas 
than in Camiri (statistically significant for Chi- 
wisivi and Camiri only [x’ = 10.7 1, df = 1, P < 
10-21). 
Clinical forms observed in Group II  patierits 
Table 2 summarizes the differences within 
Group II. Only 1 case of megaoesophagus with- 
out cardiac change was identified (0.07%). Con- 
sidering the different clinical forms (asympto- 
matic, cardiac, digestive, and associated), no 
significant difference was observed between pa- 
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FIGURE 1. Electrophoretic profiles of 3 strains of T. crzczi isolated from patients by xenodiagnosis. Enzyme 
systems shown are (A) GPI, (B) IDH, (C) ME, and (D) PGM. Lanes 2 and 3 show strains isolated from 2 
xenodiagnosis triatomine bugs from a single patient (typical patterns of zymodemes 39 and 20, respectively). 
Lanes 1 show stock isolated from a single xenodiagnosis triatomine bug from a single patient (typical pattern 
of a mixture of zymodemes 39 and 20). 
tients infected either in Cochabamba or Sucre. 
Samples from others cities were too small for 
comparisons. Among the patients who presented 
with gastrointestinal changes, 42.20/0 had a severe 
megacolon (Grade III), 50.3% had a moderate 
megacolon (Grade II), and 7.5% had a megacolon 
with minor changes (Grade I). The different fre- 
quencies of cardiac abnormalities were as fol- 
lows: Bradycardia, 63.8%; right branch block, 
50%; left anterior hemiblock, 38.8%; ventricular 
premature beat, 8.3%; and incomplete right bun- 
dle branch block, ischemia, and atrial fibrilla- 
tion, 2.7% each. Ofthese patients, 36% presented 
with 2 associated cardiac abnormalities, while 
16.6% presented with 3 associated abnormali- 
ties. Two patients had pacemaker devices related 
to Chagas cardiopathy. 
Zymoderne variability of T. cruzi strains 
isolated from humans 
T. cruzi zymodemes identified among strains 
isolated from 89 Bolivian patients are presented 
in Table 3. Eleven patients from this sample 
(1 2 . 3 % )  presented with mixed infections of 2 dif- 
ferent zymodemes. These existed within 2 dif- 
ferent sets of circumstances: a typical mixed is- 
oenzyme pattern (which could be checked for 4 
enzyme systems) of 1 stock isolated from 1 xe- 
nodiagnosis triatomine bug from a single patient, 
and 2 different isoenzymic patterns in 2 strains 
from 2 xenodiagnosis triatomine bugs from a 
single patient (Fig. 1). In the present sample, 9 
different zymodemes (the genotypes of which are 
presented in Table 4) were identified. Seven zym- 
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TABLE 4 
Genotypes of Bolivian zymodemes isolated from humans identified by assaying 12 isozyme loci 
Locus and genotype 
Zymodeme' G6pd Gpi Gdh-1 Gdh-2 Idh Me-1 Me-2 Pep-I Pep-2 Pgm 6pgd 
NPlt  5/5 5/5 3/3 2/2 1/1 2/2 4/4 3/3 l / I  3/3 4/4 
I 6/6 5/5 3/3 2/2 1/1 2/2 4/4 1/1 U 1  3/3 4/4 
19 5/5 5/5 3/3 2/2 1 /1  2/2 4/4 1/1 II1 3/3 4/4 
20 5/5 5/5 3/3 2/2 II1 2/2 4/4 l / l  II1 3/3 214 
32 2/2 3/3 2/2 5/5 2/2 2/2 6/6 5/5 1/1 10/12 1/1 
39 4/4 2/4 1 /1  1/1 2/2 I/I 5/5 5/5 1/1 6/10 1/4 
40 4/4 3/4 I I 1  II1 2/2 III 5/5 4/4 1/1 4/11 114 
43 3/3 3/4 2/2 4/4 2/2 I I I  5 /5  4/4 1/1 4/11 1/4 
NP2 6/6 5/5 3/3 4/4 I/I 3/3 4/4 -$ II1 4/4 214 
* Zymodeme numbering according to Tibayrenc and others! 
'f This zymndeme differed from zymodeme 2 by 1 locus: genotype 5/5 for G6pd instead of 6/6. 
$New electrophoretic position located between bands corresponding to genotypes 1/1 and 2/2. 
NP = new profile. 
For each locus, allele 1 codes for the fastest electromorph. Mdh is not listed because it is monomorphic within this sample (genotype 212). 
odemes had been previously described,8 and 2 
had never been observed before; 1 of the latter 
appeared to be closely related to zymodeme 2,8 
with 2 allelic differences out of 24 alleles distin- 
guishable using 12 enzyme loci. The other zym- 
odeme appeared to be related to zymodeme 68 
(6 allelic differences out of 24 alleles) (Table 4). 
We do not give any numbers to these new zym- 
odemes, since their phylogenic relationship to 
those formerly described have to be assayed for 
a broader range of isozyme loci. In this sample, 
the most frequent zymodemes were 19, 20, and 
39,8 which were already recorded in triatomine 
bugs sampled from various regions of Bolivia 
(Cochabamba, Sucre, Santa-Cruz),i2 and which 
have been observed in wide geographical ranges 
in South ame rica.'^^ 
The genetic and patristicszioJ1 (or evolution- 
'I+, 
* O  
6 13  
FIGURE 2. A minimum-length unrooted Wagner network of 5 1 steps linking the 9 zymodemes of T. cruzi 
identified in the present study. The boxed numbers correspond to the zymodemes, according to the numbering 
of Tibayrenc and others.* The numbers along the branches are the patristic (or evolutionary) distances among 
the zymodemes. 
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TABLE 5 
Matrix o, jatristic (above the diagonal) and genetic (below the diagonal) distances among 9 T. cruzi zymodemes 
isolatedfroin 89 Bolivian patients using 12 isoenzyme loci 
Zymodeme 
Zymodeme NP1 7 19 20 32 39 40 43 NP2 
NP 1 - 4 2 3 
2 3 
1 19 0.08 0.08 - 
20 0.13 0.13 0.02 - 
32 1.36 1.36 1.36 1.34 
39 1.60 1.60 1.60 1.58 
40 1.60 1.60 1.60 1.58 
43 1.60 1.60 1.60 1.58 
NP2 0.54 0.39 0.54 0.52 
7 0.18 - 21 23 
21 
24 
- 
0.89 
1.14 
1.14 
1.65 
29 
31 
29 
30 
26 
- 
0.18 
0.60 
1.49 
21 
23 
21 
22 
18 
8 
0.37 
1.29 
- 
21 
23 
21 
22 
18 
14 
6 
0.98 
- 
11 
13 
11 
12 
22 
30 
22 
22 
- 
ary) distances observed among zymodemes are 
given in Table 5. The Wagner network8JoJ1 de- 
picting their phylogenic relationships is shown 
in Figure 2. 
Zymodemes and pathologies 
Among patients presenting with a given ana- 
tomic picture and infected by only l zymodeme, 
a statistical analysis was carried out for checking 
the possible association between anatomic 
changes and the more frequent T. cruzi zymo- 
demes found in our study: we plotted into 1 group 
those patients infected with either zymodemes 
7, 19, or 20, since these zymodemes are closely 
related to each other.* The second group was 
composed of patients infected with zymodeme 
39, which is radically dissimilar from zymo- 
demes 7, 19, and 20.8 The otherzymodemes were 
scarcely sampled, which made their use for sta- 
tistical analyses impossible. Table 6 summarizes 
the pathologies observed in the 2 groups of pa- 
tients defined above. 
Several patients frorn these 2 different sets pre- 
TABLE 6 
Numbers of patients infected by given zymodemes by clinical form 
Zymodeme& 
Clinical groups ECG abnormalities* Megacolont 7, 19, or 20 39 
Asymptomatic (n = 11) N N 6 5 
Cardiac (n = 10) B N 2 1 
LAH N 1 1 
VPB N O 1 
RBBB N 1 O 
LAH + B N O 1 
RBBB + B N 1 O 
RBBB + LAH N 1 O 
Megacolon (n = 6) N DI 1 O 
N DI1 3 1 
N DI11 1 O 
Associated (n = 3) B DI1 1 O 
RBBB + AJ? + VPB MI, DI11 1 O 
RBBB + LAH DI1 1 3 
Not classified (n = 7) N not done 3 2 
RBBB not done 1 O 
A V B + B  not done O 1 
Total (n = 37) 24 16 
* N = normal, B = bradycardia, LA€I = left anterior hemiblock, VPB = ventricular premature beat, RBBB = right bundle branch block, AF = 
"DI, DII, DIII, MI, MII, and MI11 = abnormal length or enlargement of the colon according to the degree of hypertrophy. 
$ Zymodeme numbering according Tibayrenc and others.8 
atrial fibrillation, and AVB = auriculo ventricular block. 
CHAGAS' DISEASE IN BOLMA: CLINICAL FORMS AND ZYMODEMES 527 
sented a cardiac and/or digestive pathology. Both 
groups of zymodemes were found significantly 
pathogenic (x2 test with the null hypothesis being 
that the zymodemes are non-pathogenic. For pa- 
tients infected by zymodemes 7, 19, or 20, x2 = 
23.33, P < anddf= 1. Forpatientsinfected 
by zymodeme 39, x2 = 9.5, P < lop2, df = 1. 
We did not find any statistical differences be- 
tween the 2 groups regarding the alternative pres- 
ence/absence of pathogenicity (x' = O. 19, P > 
0.30, df = 1). Numbers of patients from each 
clinical group were too small to allow a statistical 
study of a possible specific association between 
a given zymodeme and the existence of either 
cardiopathy or a megacolon. 
DISCUSSION 
Clinical and serological features 
of Chagas' disease in Bolivia 
The high rates of positive serology observed 
in the 3 endemic areas studied clearly shows the 
extensive distribution of Chagas' disease in Bo- 
livia. We observed important differences in the 
index of serology between Chiwisivi and Salinas, 
and between the rates of cardiopathy in the 3 
areas. The different anatomic changes observed 
in Bolivian patients have already been reported 
in the framework of Chagas' disease; however, 
we observed a particularly low frequency of me- 
gaoesophagus in this country compared to the 
frequencies observed in endemic areas of Bahia, 
G o i a ~ , ' ~ , ' ~  and Minas Gerais. I5 These results 
confirm the heterogenity of the different anatom- 
ic changes seen in Chagas' disease endemic areas.' 
Zynzodenae variability: human hosts 
front Bolivia 
Extensive isoenzyme studies of T. cruzi iso- 
lated from T. infestans, the main domestic vector 
in Bolivia, have been done.I2 We report zymo- 
deme variability among strains isolated from hu- 
mans in the same country. Our results show that 
the zymodeme variability is comparable among 
strains isolated from triatomine insectsI2 and from 
humans. Ifwe compare strains isolated from tria- 
tomine insects with strains isolated from humans 
in the areas of Cochabamba, Sucre, and Santa- 
Cruz, the numbers of strains pertaining to zym- 
odemes 19 and 20 and to zymodeme 39 are not 
significantly different (x2 = 2.22, df = 1, P > 
0.05). This strongly suggests a lack of selection, 
either by humans or by triatomine bugs, for any 
of the 3 zymodemes. 
Genetic and patristic distances calculated be- 
tween the zymodemes studied here, which rep- 
resent a geographically limited sample, reveal 
high genetic variability (Table 5). Clustering the 
zymodemes into a few, strictly separated 
subgroups was impossible (Fig. 2). This confirms 
previous data.s 
Close synpatrical circulation of 
Bolivian zyrnodemes 
The existence of mixtures of 2 2  different zym- 
odemes has been reported from Bolivia in tria- 
tomine vectors as well as in humans.6J2J6 We 
report here new cases of mixed human infections 
and describe several cases of double infections 
with zymodemes genetically unrelated* (20 and 
39, 40 and 20) or, in contrast, closely related to 
each other8 (20 and 7). Thus, mixed infections 
appear to be common in Bolivia. This phenom- 
enon has not been noted neither in Brazilian nor 
in Chilean endemic This may be be- 
cause other authors have used different sampling, 
culture, and electrophoresis techniques. Tibayr- 
enc and others, using techniques comparable to 
the present ones, have described cases of mixed 
strains in Chilean  sample^.^.^ 
Zyrnodemes and pathology 
Serological and clinical data of the present study 
have shown important differences between the 
Chiwisivi area and the Camiri and Salinas areas, 
which are only 50 km apart. It is worth noting 
that previous studies have identified very differ- 
ent zymodeme variability in the Chiwisivi and 
Camiri regions. Of 14 1 strains of T. cruzi isolated 
from T. infestans in Chiwisivi, 99% presented a 
similar isozyme profile corresponding to zymo- 
deme 9. In Camiri, a much higher range of ge- 
netic variability has been recorded 5 different 
zymodemes from only 15 strains isolated from 
T. infestans (Table 1).12 This observation is con- 
sistent with the working hypothesis of specific 
pathogenic properties of the zymodemes, but has 
of course to be examined on a broader scale. 
In view of the clinical diversity of Chagas' dis- 
ease and the presence in Bolivia of 2 radically 
dissimilar, widespread zymodemes, we decided 
to check for a possible statistical association be- 
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tween pathologies and zymodemes. Such an as- 
sociation was impossible to evidence, which con- 
firms our previous results. l6 Moreover, the 3 more 
frequent zymodemes (19, 20, and 39) did not 
show significant differences in their pathogenic- 
ity, and have all been found in patients present- 
ing cardiac or gastrointestinal (megacolon) or as- 
sociated alterations. Although the present sample 
is too small for statistical analysis of a possible 
association between zymodeme variability and 
specific pathological changes, these results sug- 
gest an absence of strict association. Neverthe- 
less, they do not rule out the hypothesis of zym- 
odeme pathogenic specificity. Indeed, several 
methodological difficulties could explain our 
negative results. For instance, xenodiagnosis, 
culture, and host immune response could act as 
:’filters,” which could select given parasite sub- 
populations from a mixed infection, in which 
case the parasite population studied by isozymes 
would not be a true picture of the 1 from the 
patient. Furthermore, mixed infections of at least 
2 different zymodemes are very frequent in Bo- 
livia (Table 3) and are probably heavily under- 
estimated, which means that human Chagas’ dis- 
ease in this country is definitely not a pure model 
for studying the problem of zymodeme patho- 
genic specificity. 
The question of the clinical consequences of 
T. cruzi genetic variability is still an unanswered 
one. In natural cycles, valuable circumstantial 
evidence could come from extensive compari- 
sons of ecologically similar regions, each har- 
boring a different type of zymodeme. To avoid 
biases due to culture and xenodiagnosis, zymo- 
deme specific DNA probes would be extremely 
valuable. Such studies should be compared to 
experimental works on animals involving statis- 
tically representative samples of cloned strains 
pertaining to various zymodemes. 
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